Interestingly, we observed that upregulating NKD1 expression could ameliorate PAH-associated pathological changes in MCT-treated mice, as evidenced by the decreased RVSP, RVHI, and attenuated intimal hyperplasia in PA. This evidence concerns the gene NKD1 and pulmonary arterial hypertension.